Loading...
menu
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
ETF
VANI
VANI
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
VANI News
Cortigent's Brain Implant Device Receives FDA Approval
Jan 29 2026
Newsfilter
Vivani Medical Prices $4.5M Offering for Growth Initiatives
Jan 26 2026
seekingalpha
Vivani Medical Launches Stock Offering to Raise $4.5 Million
Jan 26 2026
NASDAQ.COM
Vivani Medical's Cortigent Unveils Orion Visual Prosthesis Insights at NANS 2026
Jan 23 2026
NASDAQ.COM
Cortigent's Orion Visual Stimulation System Completes 6-Year Feasibility Study
Jan 22 2026
Newsfilter
Vivani Medical Shares Business Update and Announces Financial Results for Third Quarter 2025
Nov 13 2025
Newsfilter
GNTA, BBIO, AMRN Surge in After-Hours Trading: Major Biotech Factors Fueling Stock Increases
Oct 29 2025
NASDAQ.COM
Vivani Medical sets share price at $1.62 for $16M offering
Oct 27 2025
SeekingAlpha
Vivani Medical to Showcase at ThinkEquity Conference on October 30, 2025
Oct 22 2025
Newsfilter
Businesses Are Already Feeling the Impact of the Shutdown
Oct 08 2025
WSJ
Vivani Medical Scheduled to Present at the Emerging Growth Conference on September 25, 2025
Sep 24 2025
Newsfilter
Live Stream Registration Now Open for Day 2 of the Emerging Growth Conference 86 on September 25
Sep 23 2025
Globenewswire
Vivani Medical Sets Record Date for Shareholder Spin-off of Cortigent Neuromodulation Subsidiary
Sep 17 2025
Newsfilter
EXCLUSIVE: Vivani Prioritizes Semaglutide-Based Implant After Promising Preclinical Data
Aug 05 2025
Benzinga
Vivani Medical Appoints Anthony Baldor as Chief Financial Officer
Jun 11 2025
Newsfilter
Vivani Medical Announces Filing of Form 10 Registration Statement for Planned Spin-Off of Cortigent Neurostimulation Business to Vivani Shareholders
May 29 2025
Newsfilter
Show More News
